SEC Form 4 · accession 0001209191-16-128687
Vanda Pharmaceuticals Inc. · VNDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael F Cola
Director
Period of report
Jun 16, 2016
Accepted (ET)
Jun 17, 2016 · 6:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001347178
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $10.93 | Jun 16, 2016 | A | 15,000 | A | — | Jun 15, 2026 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1Option granted upon conclusion of annual meeting of stockholders pursuant to the provisions of the Issuer's outside director compensation program providing for annual option grants for outside directors.
- F2Exercisable in equal monthly installments over 12 months starting one month after the grant date, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.